Before aphaeresis, all donors of PBSC were treated subcutaneously once a day with G-CSF (Rhne-Poulenc Rorer, Lyon, France or Amgen-Roche Inc., Thousand Oaks, CA, USA), 10 g/kg/day for 4 to 6 days 63
Research on GLP-1 Medications for Treating SUDs Animal studies consistently demonstrate GLP-1 receptor agonists reduce alcohol, nicotine, and opioid consumption (Srinivasan et al., 2025)
"Transforming obesity: The advancement of multi-receptor drugs." Cell 187.15 (2024): 3829-3853.
Stopping nitrous oxide may not be enough for you to get better
Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats